BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 16339513)

  • 1. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor.
    Rosen DB; Bettadapura J; Alsharifi M; Mathew PA; Warren HS; Lanier LL
    J Immunol; 2005 Dec; 175(12):7796-9. PubMed ID: 16339513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.
    Rosen DB; Cao W; Avery DT; Tangye SG; Liu YJ; Houchins JP; Lanier LL
    J Immunol; 2008 May; 180(10):6508-17. PubMed ID: 18453569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
    Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
    J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes.
    Białoszewska A; Olkowska-Truchanowicz J; Bocian K; Osiecka-Iwan A; Czop A; Kieda C; Malejczyk J
    J Immunol; 2018 Jan; 200(2):715-724. PubMed ID: 29212911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.
    Lanier LL; Chang C; Phillips JH
    J Immunol; 1994 Sep; 153(6):2417-28. PubMed ID: 8077657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially induced expression of C-type lectins in activated lymphocytes.
    Eichler W; Ruschpler P; Wobus M; Drössler K
    J Cell Biochem Suppl; 2001; Suppl 36():201-8. PubMed ID: 11455585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity.
    Grazia Cifone M; Roncaioli P; Cironi L; Festuccia C; Meccia A; D'Aló S; Botti D; Santoni A
    J Immunol; 1997 Jul; 159(1):309-17. PubMed ID: 9200468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity.
    Ryan JC; Niemi EC; Nakamura MC; Seaman WE
    J Exp Med; 1995 May; 181(5):1911-5. PubMed ID: 7722466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver.
    Ishihara S; Nieda M; Kitayama J; Osada T; Yabe T; Ishikawa Y; Nagawa H; Muto T; Juji T
    Eur J Immunol; 1999 Aug; 29(8):2406-13. PubMed ID: 10458753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells.
    Yu S; Zhu Y; Chen Z; Alheim M; Ljungberg A; Zhu J
    J Neurosci Res; 2002 Mar; 67(6):823-8. PubMed ID: 11891797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.
    Tanaka M; Fine JH; Kirkham CL; Aguilar OA; Belcheva A; Martin A; Ketela T; Moffat J; Allan DSJ; Carlyle JR
    Cancer Res; 2018 Jul; 78(13):3589-3603. PubMed ID: 29691253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.
    Exley M; Porcelli S; Furman M; Garcia J; Balk S
    J Exp Med; 1998 Sep; 188(5):867-76. PubMed ID: 9730888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKR-P1dim/TCR alpha beta + T cells and natural killer cells share expression of NKR-P1A and NKR-P1D.
    Appasamy PM; Kenniston TW; Brissette-Storkus CS; Chambers WH
    Nat Immun; 1996-1997; 15(5):259-68. PubMed ID: 9390275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B.
    Li J; Rabinovich BA; Hurren R; Shannon J; Miller RG
    Int Immunol; 2003 Mar; 15(3):411-6. PubMed ID: 12618485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.
    Kita S; Matsubara H; Kasai Y; Tamaoki T; Okabe Y; Fukuhara H; Kamishikiryo J; Krayukhina E; Uchiyama S; Ose T; Kuroki K; Maenaka K
    Eur J Immunol; 2015 Jun; 45(6):1605-13. PubMed ID: 25826155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression and purification of soluble form of human natural killer cell receptor NKR-P1 in HEK293S GnTI
    Bláha J; Kalousková B; Skořepa O; Pažický S; Novák P; Vaněk O
    Protein Expr Purif; 2017 Dec; 140():36-43. PubMed ID: 28757467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.
    Bambard ND; Mathew SO; Mathew PA
    Scand J Immunol; 2010 Mar; 71(3):210-9. PubMed ID: 20415786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of intrathymic T, NK, and dendritic cell (DC) progenitors in fetal and adult rats: demonstration of a bipotent T/DC intermediate precursor.
    Alonso-C LM; Muñoz JJ; Zapata AG
    J Immunol; 2001 Oct; 167(7):3635-41. PubMed ID: 11564776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LLT1-CD161 Interaction in Cancer: Promises and Challenges.
    Braud VM; Meghraoui-Kheddar A; Elaldi R; Petti L; Germain C; Anjuère F
    Front Immunol; 2022; 13():847576. PubMed ID: 35185935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.